IN2014DN09091A - - Google Patents
Info
- Publication number
- IN2014DN09091A IN2014DN09091A IN9091DEN2014A IN2014DN09091A IN 2014DN09091 A IN2014DN09091 A IN 2014DN09091A IN 9091DEN2014 A IN9091DEN2014 A IN 9091DEN2014A IN 2014DN09091 A IN2014DN09091 A IN 2014DN09091A
- Authority
- IN
- India
- Prior art keywords
- oral formulation
- substrate
- water
- gelling agent
- sugar alcohol
- Prior art date
Links
- 238000009472 formulation Methods 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 4
- 239000003349 gelling agent Substances 0.000 abstract 2
- 150000004676 glycans Chemical class 0.000 abstract 2
- 229920001282 polysaccharide Polymers 0.000 abstract 2
- 239000005017 polysaccharide Substances 0.000 abstract 2
- 239000000758 substrate Substances 0.000 abstract 2
- 150000005846 sugar alcohols Chemical class 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 241000220479 Acacia Species 0.000 abstract 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 abstract 1
- 229920002774 Maltodextrin Polymers 0.000 abstract 1
- 239000005913 Maltodextrin Substances 0.000 abstract 1
- 229920001218 Pullulan Polymers 0.000 abstract 1
- 239000004373 Pullulan Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940035034 maltodextrin Drugs 0.000 abstract 1
- 238000004321 preservation Methods 0.000 abstract 1
- 235000019423 pullulan Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261640474P | 2012-04-30 | 2012-04-30 | |
| US201361783163P | 2013-03-14 | 2013-03-14 | |
| PCT/JP2013/062985 WO2013165021A1 (en) | 2012-04-30 | 2013-04-30 | Oral formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN09091A true IN2014DN09091A (cg-RX-API-DMAC7.html) | 2015-05-22 |
Family
ID=48483123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN9091DEN2014 IN2014DN09091A (cg-RX-API-DMAC7.html) | 2012-04-30 | 2013-04-30 |
Country Status (21)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109498556A (zh) * | 2017-09-15 | 2019-03-22 | 万特制药(海南)有限公司 | 阿立哌唑口服溶液及其制备方法 |
| WO2022176017A1 (ja) * | 2021-02-16 | 2022-08-25 | 大塚製薬株式会社 | 非晶質体及び当該非晶質体を含む組成物 |
| US11654108B1 (en) | 2022-05-02 | 2023-05-23 | Medicated Chews, Llc | Sennoside medicated chews |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6517886B1 (en) * | 1997-06-24 | 2003-02-11 | Biovail Corporation International | Positive hydration method of preparing confectionery and the resulting product |
| AUPQ970300A0 (en) * | 2000-08-29 | 2000-09-21 | Massa Nominees Pty Ltd | Advanced wireless network |
| FR2822644B1 (fr) * | 2001-03-30 | 2005-03-11 | Roquette Freres | Confiserie sans sucre |
| JP2004099558A (ja) * | 2002-09-11 | 2004-04-02 | Medorekkusu:Kk | 医薬用ゼリー組成物 |
| JP4547994B2 (ja) * | 2004-06-02 | 2010-09-22 | 救急薬品工業株式会社 | 塊状物質含有積層フィルム状の可食性口腔内投与剤の製造方法および塊状物質含有積層フィルム状の可食性口腔内投与剤 |
| JP4315393B2 (ja) | 2005-04-14 | 2009-08-19 | 大塚製薬株式会社 | 複素環化合物 |
| WO2008050847A1 (en) * | 2006-10-25 | 2008-05-02 | Dainippon Sumitomo Pharma Co., Ltd. | Granular preparation prevented from caking |
| AU2008237246B2 (en) * | 2007-04-05 | 2014-06-05 | University Of Kansas | Rapidly dissolving pharmaceutical compositions comprising pullulan |
| GB0818472D0 (en) * | 2008-10-08 | 2008-11-12 | Probio Nutraceuticals As | Composition |
| WO2010116385A2 (en) * | 2009-04-08 | 2010-10-14 | Rubicon Research Private Limited | Pharmaceutical compositions for alleviating unpleasant taste |
| KR101074271B1 (ko) * | 2009-06-25 | 2011-10-17 | (주)차바이오앤디오스텍 | 불쾌한 맛을 효과적으로 은폐한 경구용 속용 필름 |
| US20110139164A1 (en) * | 2009-12-15 | 2011-06-16 | R. J. Reynolds Tobacco Company | Tobacco Product And Method For Manufacture |
| GB201006200D0 (en) * | 2010-04-14 | 2010-06-02 | Ayanda As | Composition |
| JP5611672B2 (ja) * | 2010-05-28 | 2014-10-22 | ゼリア新薬工業株式会社 | 経口ゼリー剤 |
| AR082494A1 (es) * | 2010-08-24 | 2012-12-12 | Otsuka Pharma Co Ltd | Composicion en torta y en suspension con contenido de derivado de carbostirilo y derivado de aceite de silicona y/o aceite de silicona |
| GB201016900D0 (en) * | 2010-10-06 | 2010-11-17 | Probio Asa | Emulsion |
| WO2014104989A1 (en) * | 2011-12-27 | 2014-07-03 | Mahmut Bilgic | Pharmaceutical compositions comprising aripiprazole |
-
2013
- 2013-04-29 AR ARP130101449 patent/AR091349A1/es unknown
- 2013-04-29 TW TW102115265A patent/TWI594765B/zh not_active IP Right Cessation
- 2013-04-30 MX MX2014013155A patent/MX2014013155A/es unknown
- 2013-04-30 WO PCT/JP2013/062985 patent/WO2013165021A1/en not_active Ceased
- 2013-04-30 EA EA201491995A patent/EA026187B1/ru not_active IP Right Cessation
- 2013-04-30 US US14/397,683 patent/US20150126521A1/en not_active Abandoned
- 2013-04-30 CN CN201380022960.1A patent/CN104271120A/zh active Pending
- 2013-04-30 HK HK15107872.1A patent/HK1207290A1/xx unknown
- 2013-04-30 EP EP13724634.4A patent/EP2844232A1/en not_active Withdrawn
- 2013-04-30 CA CA 2872004 patent/CA2872004A1/en not_active Abandoned
- 2013-04-30 IN IN9091DEN2014 patent/IN2014DN09091A/en unknown
- 2013-04-30 SG SG11201406261QA patent/SG11201406261QA/en unknown
- 2013-04-30 AU AU2013255256A patent/AU2013255256B2/en not_active Ceased
- 2013-04-30 KR KR1020147033472A patent/KR20150003898A/ko not_active Withdrawn
- 2013-04-30 JP JP2014553002A patent/JP6360795B2/ja active Active
- 2013-04-30 BR BR112014026879A patent/BR112014026879A2/pt not_active IP Right Cessation
- 2013-04-30 SG SG10201608954UA patent/SG10201608954UA/en unknown
- 2013-04-30 NZ NZ630029A patent/NZ630029A/en not_active IP Right Cessation
-
2014
- 2014-10-17 PH PH12014502323A patent/PH12014502323A1/en unknown
- 2014-10-19 IL IL235111A patent/IL235111A0/en unknown
- 2014-11-06 ZA ZA2014/08114A patent/ZA201408114B/en unknown
- 2014-11-26 CO CO14260294A patent/CO7151505A2/es unknown
-
2017
- 2017-04-05 US US15/479,409 patent/US20170202833A1/en not_active Abandoned
- 2017-10-27 US US15/795,500 patent/US20180055840A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IL235111A0 (en) | 2014-12-31 |
| CO7151505A2 (es) | 2014-12-29 |
| ZA201408114B (en) | 2016-08-31 |
| CA2872004A1 (en) | 2013-11-07 |
| PH12014502323A1 (en) | 2015-01-12 |
| JP2015515959A (ja) | 2015-06-04 |
| EP2844232A1 (en) | 2015-03-11 |
| AR091349A1 (es) | 2015-01-28 |
| HK1207290A1 (en) | 2016-01-29 |
| WO2013165021A1 (en) | 2013-11-07 |
| MX2014013155A (es) | 2015-05-08 |
| NZ630029A (en) | 2016-05-27 |
| SG10201608954UA (en) | 2016-12-29 |
| EA026187B1 (ru) | 2017-03-31 |
| TW201347773A (zh) | 2013-12-01 |
| SG11201406261QA (en) | 2014-11-27 |
| US20150126521A1 (en) | 2015-05-07 |
| JP6360795B2 (ja) | 2018-07-18 |
| KR20150003898A (ko) | 2015-01-09 |
| AU2013255256A2 (en) | 2014-11-13 |
| TWI594765B (zh) | 2017-08-11 |
| AU2013255256A1 (en) | 2014-10-30 |
| US20170202833A1 (en) | 2017-07-20 |
| CN104271120A (zh) | 2015-01-07 |
| EA201491995A1 (ru) | 2015-02-27 |
| US20180055840A1 (en) | 2018-03-01 |
| AU2013255256B2 (en) | 2017-09-07 |
| BR112014026879A2 (pt) | 2017-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2014039903A3 (en) | Stable aqueous formulations of adalimumab | |
| MY187540A (en) | Compounds active towards bromodomains | |
| CL2014001829A1 (es) | Compuestos derivados de indolizina; procedimiento de preparación; composiciones farmacéuticas que los contienen y uso en el tratamiento del cancer. | |
| AR081681A1 (es) | METODOS Y COMPOSICIONES PARA LA ADMINISTRACION INTRATECAL DE b-GALACTOCEREBROSIDASA | |
| WO2012024620A3 (en) | Autotaxin inhibitors and uses thereof | |
| MX2016008448A (es) | Conjugados de var2csa-farmaco. | |
| EP3177271A4 (en) | Liquid formulation compositions, medicament delivery devices, and methods of preparation and use thereof | |
| EP3151923A4 (en) | Clear compositions and methods for the delivery of active ingredients for skin care | |
| EP3878445A3 (en) | Acamprosate formulations, methods of using the same, and combinations comprising the same | |
| EP3034082A4 (en) | Pharmaceutical composition for treating or preventing neuropsychitric disease, containing flavone-6-c-glucose derivatives as active ingredients | |
| WO2014144295A8 (en) | Ceftolozane antibiotic compositions | |
| PH12014500859A1 (en) | Pharmaceutical compositions comprising dgla and/or 15-hetre and methods of use thereof | |
| MX2013013649A (es) | Compuestos de quinona para tratar enfermedades mediadas por ape1. | |
| UA110979C2 (uk) | Рідка фармацевтична композиція, яка включає нітизинон | |
| PH12012501548A1 (en) | Compositions comprising sugar-cysteine products | |
| AU2016356504A8 (en) | 5-hydroxytryptamine 1B receptor-stimulating agent for enhancing in vivo engraftment potential | |
| PH12014502323A1 (en) | Oral formulation | |
| MX2014015199A (es) | Formulacion de pexiganan estable. | |
| WO2014133811A3 (en) | Compounds from invasive salvinias and methods of using the same | |
| AU2012345659A8 (en) | Acamprosate formulations, methods of using the same, and combinations comprising the same | |
| WO2011130692A3 (en) | Androgen induced oxidative stress inhibitors | |
| MX2015015537A (es) | Formulacion de pastillas de nicotina. | |
| TR200909786A1 (tr) | Sefiksim içeren efervesan tablet ve granül formülasyonu. | |
| IT1399492B1 (it) | Composizioni farmaceutiche effervescenti contenenti n-acetilcisteina. | |
| IT1400808B1 (it) | Estratti da vinaccioli, metodo di preparazione e uso degli stessi per il trattamento di vini. |